Schmitt Inds Inc (SMIT) 1.59 $SMIT Schmitt Indu
Post# of 273332

Schmitt Industries, Inc. Announces the Listing of a Portion of Real Estate Holdings
GlobeNewswire - Wed Aug 03, 3:19PM CDT
Schmitt Industries, Inc. (NASDAQ:SMIT) (the "Company"

SMIT: 1.59 (-0.01)
Schmitt Industries Announces Annual Meeting Date
GlobeNewswire - Wed Jul 27, 5:00PM CDT
Schmitt Industries (Nasdaq:SMIT) announced today that its Annual Meeting of Shareholders will be held on Friday, October 7, 2016 at 3:00 p.m. local time, at the Company's headquarters at 2765 NW Nicolai St., Portland, Oregon.
SMIT: 1.59 (-0.01)
Schmitt Industries, Inc. Appoints Charlie Davidson to its Board
GlobeNewswire - Wed Jun 01, 3:10PM CDT
Schmitt Industries, Inc. (NASDAQ:SMIT) (the "Company"


SMIT: 1.59 (-0.01)
Schmitt Industries Announces Management Changes
GlobeNewswire - Mon Jan 11, 8:25AM CST
Schmitt Industries, Inc. (NASDAQ:SMIT) (the "Company"

SMIT: 1.59 (-0.01)
Schmitt Industries Announces First Quarter Fiscal 2016 Operating Results
GlobeNewswire - Fri Oct 02, 3:15PM CDT
Schmitt Industries, Inc. (NASDAQ:SMIT) today announced its operating results for the quarter ended August 31, 2015. For the three months ended August 31, 2015, total sales increased $55,096, or 1.8%, to $3,104,384 from $3,049,288 for the three months ended August 31, 2014. Net loss was $195,062, or $(0.07) per fully diluted share, for the three months ended August 31, 2015 as compared to net income of $51,783, or $0.02 per fully diluted share, for the three months ended August 31, 2014.
SMIT: 1.59 (-0.01)
Schmitt Industries Announces Fourth Quarter and Fiscal 2015 Operating Results
GlobeNewswire - Fri Jul 24, 3:10PM CDT
Schmitt Industries, Inc. (NASDAQ:SMIT) today announced its operating results for the fourth quarter and fiscal year ended May 31, 2015. For the three months ended May 31, 2015, total sales increased $831,837, or 27.5%, to $3,857,681 from $3,025,844 for the three months ended May 31, 2014. Net income was $92,759, or $0.03 per fully diluted share, for the three months ended May 31, 2015 as compared to net loss of $157,757, or $(0.05) per fully diluted share, for the three months ended May 31, 2014. For the fiscal year ended May 31, 2015, total sales increased $934,585, or 7.7%, to $13,069,091 from $12,134,506 for the fiscal year ended May 31, 2014. Net loss was $93,669, or $(0.03) per fully diluted share, for the fiscal year ended May 31, 2015 as compared to net loss of $539,624, or $(0.18) per fully diluted share, for the fiscal year ended May 31, 2014.
SMIT: 1.59 (-0.01)
Schmitt Industries Announces Third Quarter Fiscal 2015 Operating Results
GlobeNewswire - Fri Apr 03, 4:20PM CDT
Schmitt Industries, Inc. (Nasdaq:SMIT) today announced its operating results for the three and nine months ended February 28, 2015. For the three months ended February 28, 2015, total sales decreased $55,545, or 1.8%, to $3,010,618 from $3,066,163 in the three months ended February 28, 2014. Net loss was $168,371, or $(0.06) per fully diluted share, for the three months ended February 28, 2015 as compared to net loss of $72,107, or $(0.02) per fully diluted share, for the three months ended February 28, 2014. For the nine months ended February 28, 2015, total sales increased $102,748, or 1.1%, to $9,211,410 from $9,108,662 in the nine months ended February 28, 2014. Net loss was $186,428, or $(0.06) per fully diluted share, for the nine months ended February 28, 2015 as compared to net loss of $381,867, or $(0.13) per fully diluted share, for the nine months ended February 28, 2014.
SMIT: 1.59 (-0.01)
Quarterly Report Card: Comprehensive Research on Remy International, RF Industries, Roka Bioscience, Schmitt Industries and Sequenom
PR Newswire - Mon Dec 22, 7:40AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including Remy International (NASDAQ: REMY), RF Industries (NASDAQ: RFIL), Roka Bioscience (NASDAQ: ROKA), Schmitt Industries (NASDAQ: SMIT), and Sequenom (NASDAQ: SQNM). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
SMIT: 1.59 (-0.01), ROKA: 0.64 (-0.04), SQNM: 2.39 (-0.01), RFIL: 1.72 (-0.06)

